Endometrial ablation in a woman with a persistent uterine hemorrhage due to acute promyelocyte leukemia: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 6, 2007, Pages 548-550

  Alperin, Marianna ^a,b   Quaas, Alexander ^a   Johnson, Natasha R ^a   Hornstein, Mark D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endometrium; Promyelocyte leukemia, acute; Radiofrequency catheter ablation; Uterine hemorrhage

Indexed keywords

ARSENIC TRIOXIDE; CONJUGATED ESTROGEN; CYTARABINE; DAUNORUBICIN; ETHINYLESTRADIOL; GELFOAM; LEUPRORELIN; MICROSPHERE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ACUTE LEUKEMIA; ADULT; AMENORRHEA; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMBINATION CHEMOTHERAPY; ENDOMETRIUM ABLATION; FEMALE; HEMATOLOGICAL PARAMETERS; HORMONAL THERAPY; HUMAN; HYSTEROSCOPY; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RADIOFREQUENCY ABLATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING;

ADULT; CATHETER ABLATION; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; TREATMENT OUTCOME; UTERINE HEMORRHAGE;

EID: 34250797369     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Aderka D, Praff G, Santo M, et al: Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy. Am J Med Sci 1986;291: 147-151
2. DeVore GR, Owens O, Kase N: Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding: A double-blind randomized control study. Obstet Gynecol 1982;59: 285-291
3. Katagiri S, Tsubakio T, Minami G, et al: Successful embolization for uterine hemorrhage in a patient with acute promyelocyte leukemia. Acta Haematol 1983;70:119-121
4. Phelan JT 2nd, Broder J, Kouides PA: Near-fatal uterine hemorrhage during induction chemotherapy for acute myeloid leukemia: A case report of bilateral uterine artery embolization. Am J Hematol 2004;77: 151-155
5. March CM. Bleeding problems and treatment. Clinical Obstet Gynecol 1998;41:928-939
6. Nichols CM, Gill EJ: Thermal balloon endometrial ablation for management of acute uterine hemorrhage. Obstet Gynecol 2002;100:1092-1094
7. Gallinat A, Nugent W: NovaSure impedance-controlled system for endometrial ablation. J Am Assoc Gynecol Laparosc 2002;9:283-289
8. Gallinat A: NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients. Am J Obstet Gynecol 2004;191:1585-1589
9. Cooper J, Gimpelson R, Laberge P, et al: A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:418-428
10. Busund B, Erno LE, Gronmark A, et al: Endometrial ablation with NovaSure GEA: A pilot study. Acta Obstet Gynecol Scand 2003;82:65-68
11. Abbott J, Hawe J, Hunter D, et al: A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 2003;80:203-208
12. Cooper J, Gimpelson RJ: Summary of safety and effectiveness data from FDA: A valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 2004;49:267-273
13. Shaw RW, Fraser HM: Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia. Br J Obstet Gynaecol 1984;91:913-916